1.
Product
Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2.
Research
Methodology
2.1.
Objective of
the Study
2.2.
Baseline
Methodology
2.3.
Key Industry
Partners
2.4.
Major
Association and Secondary Sources
2.5.
Forecasting
Methodology
2.6.
Data
Triangulation & Validation
2.7.
Assumptions
and Limitations
3.
Executive
Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4.
Voice of Customer
5. Global Medication Adherence Devices Market Outlook
5.1.
Market Size & Forecast
5.1.1.
By Value
5.2.
Market Share & Forecast
5.2.1. By
Type (Hardware Centric v/s Software Centric)
5.2.2. By
Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology,
Gastrointestinal, Musculoskeletal, Others)
5.2.3. By
Region (North America, Europe, Asia Pacific, South America, Middle East &
Africa)
5.2.4. By
Company (2022)
5.3.
Market Map
5.3.1 By Type
5.3.2 By Medication
5.3.3 By Region
6. North America Medication
Adherence Devices Market Outlook
6.1.
Market Size & Forecast
6.1.1.
By Value
6.2.
Market Share & Forecast
6.2.1.
By Type (Hardware Centric v/s Software Centric)
6.2.2.
By Medication (Cardiovascular, Central Nervous System,
Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others)
6.2.3.
By Country
6.3.
North America: Country Analysis
6.3.1.
United States Medication Adherence Devices Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Type
6.3.1.2.2.
By Medication
6.3.2.
Canada Medication Adherence Devices Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Type
6.3.2.2.2.
By Medication
6.3.3.
Mexico Medication Adherence Devices Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Type
6.3.3.2.2.
By Medication
7. Europe Medication
Adherence Devices Market Outlook
7.1.
Market Size & Forecast
7.1.1.
By Value
7.2.
Market Share & Forecast
7.2.1.
By Type (Hardware Centric v/s Software Centric)
7.2.2.
By Medication (Cardiovascular, Central Nervous System,
Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others)
7.2.3. By Country
7.3.
Europe: Country Analysis
7.3.1.
France Medication Adherence Devices Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Type
7.3.1.2.2.
By Medication
7.3.2.
Germany Medication Adherence Devices Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Type
7.3.2.2.2.
By Medication
7.3.3.
United Kingdom Medication Adherence Devices Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Type
7.3.3.2.2.
By Medication
7.3.4.
Italy Medication Adherence Devices Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Type
7.3.4.2.2.
By Medication
7.3.5.
Spain Medication Adherence Devices Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Type
7.3.5.2.2.
By Medication
8. Asia-Pacific Medication
Adherence Devices Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value
8.2.
Market Share & Forecast
8.2.1.
By Type (Hardware Centric v/s Software Centric)
8.2.2.
By Medication (Cardiovascular, Central Nervous System,
Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others)
8.2.3.
By Country
8.3.
Asia-Pacific: Country Analysis
8.3.1.
China Medication Adherence Devices Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Type
8.3.1.2.2.
By Medication
8.3.2.
India Medication Adherence Devices Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Type
8.3.2.2.2.
By Medication
8.3.3.
Japan Medication Adherence Devices Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Type
8.3.3.2.2.
By Medication
8.3.4.
South Korea Medication Adherence Devices Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Type
8.3.4.2.2.
By Medication
8.3.5.
Australia Medication Adherence Devices Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Type
8.3.5.2.2.
By Medication
9. South America Medication
Adherence Devices Market Outlook
9.1.
Market Size & Forecast
9.1.1.
By Value
9.2.
Market Share & Forecast
9.2.1.
By Type (Hardware Centric v/s Software Centric)
9.2.2.
By Medication (Cardiovascular, Central Nervous System,
Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others)
9.2.3.
By Country
9.3.
South America: Country Analysis
9.3.1.
Brazil Medication Adherence Devices Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Type
9.3.1.2.2.
By Medication
9.3.2.
Argentina Medication Adherence Devices Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Type
9.3.2.2.2.
By Medication
9.3.3.
Colombia Medication Adherence Devices Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Type
9.3.3.2.2.
By Medication
10. Middle East and
Africa Medication Adherence Devices Market Outlook
10.1.
Market Size & Forecast
10.1.1.
By Value
10.2.
Market Share & Forecast
10.2.1.
By Type (Hardware Centric v/s Software Centric)
10.2.2.
By Medication (Cardiovascular, Central Nervous System,
Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others)
10.2.3.
By Country
10.3.
MEA: Country Analysis
10.3.1.
South Africa Medication Adherence Devices Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Type
10.3.1.2.2.
By Medication
10.3.2.
Saudi Arabia Medication Adherence Devices Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Type
10.3.2.2.2.
By Medication
10.3.3.
UAE Medication Adherence Devices Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Type
10.3.3.2.2.
By Medication
11.
Market Dynamics
11.1.
Drivers
11.2.
Challenges
12.
Market Trends & Developments
12.1.
Recent Development
12.2.
Mergers &
Acquisitions
12.3.
Product Launches
13. Global
Medication Adherence Devices Market: SWOT Analysis
14. Porter’s
Five Forces Analysis
14.1.
Competition in the Industry
14.2.
Potential of New Entrants
14.3.
Power of Suppliers
14.4.
Power of Customers
14.5.
Threat of Substitute Products
15.
Competitive Landscape
15.1.
Business Overview
15.2.
Product Offerings
15.3.
Recent Developments
15.4.
Financials (As Reported)
15.5.
Key Personnel
15.6.
SWOT Analysis
15.6.1.
Becton, Dickinson, and Company (CareFusion)
15.6.2.
DrFirst.com,Inc.
15.6.3.
AdhereTech Inc.
15.6.4.
MedMinder.
15.6.5.
Caredose.
15.6.6.
Fruitech Ltd.
15.6.7.
PHC Holdings Corporation.
15.6.8.
MedAdvisor International Pty Ltd.
16. Strategic Recommendations